RWM
RDY icon

Ritholtz Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Ritholtz Wealth Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$312K Sell
21,515
-2,599
-11% -$35.1K ﹤0.01% 1038
2026
Q1 		$334K Sell
24,114
-3,678
-13% -$51.2K 0.01% 932
2025
Q4 		$390K Sell
27,792
-1,731
-6% -$24.3K 0.01% 804
2025
Q3 		$413K Sell
29,523
-2,772
-9% -$39.9K 0.01% 737
2025
Q2 		$485K Sell
32,295
-11,006
-25% -$157K 0.01% 651
2025
Q1 		$571K Sell
43,301
-37,294
-46% -$515K 0.02% 559
2024
Q4 		$1.27M Sell
80,595
-6,480
-7% -$97.3K 0.04% 316
2024
Q3 		$1.38M Buy
87,075
+7,840
+10% +$126K 0.04% 304
2024
Q2 		$1.21M Buy
79,235
+235
+0.3% +$3.37K 0.04% 311
2024
Q1 		$1.16M Buy
79,000
+10,115
+15% +$148K 0.04% 318
2023
Q4 		$959K Buy
68,885
+16,385
+31% +$219K 0.04% 338
2023
Q3 		$702K Buy
52,500
+17,515
+50% +$237K 0.03% 373
2023
Q2 		$442K Buy
34,985
+5,060
+17% +$59.1K 0.02% 458
2023
Q1 		$341K Buy
29,925
+5,780
+24% +$62.4K 0.02% 488
2022
Q4 		$250K Buy
24,145
+3,710
+18% +$40K 0.01% 495
2022
Q3 		$214K Sell
20,435
-140
-0.7% -$1.49K 0.01% 638
2022
Q2 		$228K Sell
20,575
-3,725
-15% -$40.5K 0.01% 472
2022
Q1 		$271K Sell
24,300
-38,280
-61% -$434K 0.02% 435
2021
Q4 		$819K Sell
62,580
-12,410
-17% -$156K 0.05% 200
2021
Q3 		$977K Sell
74,990
-23,635
-24% -$315K 0.07% 147
2021
Q2 		$1.45M Buy
98,625
+23,320
+31% +$326K 0.1% 91
2021
Q1 		$925K Buy
75,305
+3,525
+5% +$45.3K 0.08% 116
2020
Q4 		$1.02M Buy
71,780
+6,480
+10% +$87.3K 0.1% 89
2020
Q3 		$908K Buy
65,300
+15,560
+31% +$185K 0.1% 83
2020
Q2 		$527K Buy
+49,740
New +$506K 0.07% 111

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Ritholtz Wealth Management's RDY Position: Q2 2026 in Review

Ritholtz Wealth Management reduced its Dr. Reddy's Laboratories (RDY) stake by 11% in Q2 2026, selling an estimated $35.1K and leaving 21,515 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #1038.

Ritholtz Wealth Management first reported a position in RDY in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.45M in Q2 2021. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Ritholtz Wealth Management held 21,515 shares of Dr. Reddy's Laboratories worth $312K as of Q2 2026.
  • Ritholtz Wealth Management sold 2,599 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $35.1K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Ritholtz Wealth Management's portfolio in Q2 2026, its #1038 holding.
  • Ritholtz Wealth Management first reported a position in Dr. Reddy's Laboratories in Q2 2020 and has held it in 25 quarters since.
  • Ritholtz Wealth Management's Dr. Reddy's Laboratories position peaked at $1.45M in Q2 2021.
  • 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.